Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Adenocarcinoma and CCND1[original query] |
|---|
| Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma. Cancer 2005 Aug 104 (4): 730-9. Casson Alan G, Zheng Zuoyu, Evans Susan C, Geldenhuys Laurette, van Zanten Sander Veldhuyzen, Veugelers Paul J, Porter Geoffrey A, Guernsey Duane |
| Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung cancer (Amsterdam, Netherlands) 2006 Mar 51 (3): 303-11. Gautschi Oliver, Hugli Barbara, Ziegler Annemarie, Bigosch Colette, Bowers Naomi L, Ratschiller Daniel, Jermann Monika, Stahel Rolf A, Heighway Jim, Betticher Daniel |
| Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Dec 14 (23): 7804-12. Gupta Vanita K, Feber Andrew, Xi Liqiang, Pennathur Arjun, Wu Maoxin, Luketich James D, Godfrey Tony |
| p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2009 Mar . Liu G, Cescon DW, Zhai R, Zhou W, Kulke MH, Ma C, Xu W, Su L, Asomaning K, Heist RS, Wain JC, Lynch TJ, Christiani DC |
| Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1472-6. Gold Philip J, Goldman Bryan, Iqbal Syma, Leichman Lawrence P, Zhang Wu, Lenz Heinz-Josef, Blanke Charles |
| Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA 2011 Jul 306 (4): 410-9. Orloff Mohammed, Peterson Charissa, He Xin, Ganapathi Shireen, Heald Brandie, Yang Yi-ran, Bebek Gurkan, Romigh Todd, Song Jee Hoon, Wu Wenjing, David Stefan, Cheng Yulan, Meltzer Stephen J, Eng Char |
| Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians. Cancer investigation 2012 Nov 30 (9): 630-6. Zhuo Wenlei, Zhang Liang, Wang Yan, Zhu Bo, Chen Zhengta |
| CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls. Molecular biology reports 2013 Jul 40 (7): 4625-35. Duan Yu-Zhong, Zhang Liang, Liu Chang-Chih, Zhu Bo, Zhuo Wen-Lei, Chen Zheng-Ta |
| Genetic polymorphism of CCND1 G870A and esophageal cancer susceptibility: A meta-analysis. Biomedical reports 2013 3 1 (2): 303-307. He Wenwu, Zeng Yanbei, Long Jianxiong, Zhou Qiuxi, Hu Yanling, Chen Ming |
| Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry. Journal of surgical oncology 2015 Mar 111 (3): 316-23. Bachmann Kai, Neumann Anna, Hinsch Andrea, Nentwich Michael F, El Gammal Alexander T, Vashist Yogesh, Perez Daniel, Bockhorn Maximilian, Izbicki Jakob R, Mann Oliv |
| Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun . Dragoj Miodrag, Milosevic Zorica, Bankovic Jasna, Dinic Jelena, Pesic Milica, Tanic Nikola, Stankovic Tija |
| SNP rs1059234 in CDKN1A Gene Correlates with Prognosis in Resected Gastric Adenocarcinoma. Clinical laboratory 2016 62 (3): 409-16. Nie Xiaojing, Wang Xiaoting, Lin Youdong, Yu Yinghao, Liu Wei, Xie Feilai, Wang Xuzhou, Tan Jianming, Huang Qiaoj |
| Polymorphisms of microRNA target genes IL12B, INSR, CCND1 and IL10 in gastric cancer. World journal of gastroenterology 2017 May 23 (19): 3480-3487. Petkevicius Vytenis, Salteniene Violeta, Juzenas Simonas, Wex Thomas, Link Alexander, Leja Marcis, Steponaitiene Ruta, Skieceviciene Jurgita, Kupcinskas Limas, Jonaitis Laimas, Kiudelis Gediminas, Malfertheiner Peter, Kupcinskas Juoz |
| Risk factors for gastroesophageal reflux disease and analysis of genetic contributors. World journal of clinical cases 2018 8 6 (8): 176-182. Argyrou Alexandra, Legaki Evangelia, Koutserimpas Christos, Gazouli Maria, Papaconstantinou Ioannis, Gkiokas George, Karamanolis Geor |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma. Cancers 2021 7 13 (14): . Izadi Fereshteh, Sharpe Benjamin P, Breininger Stella P, Secrier Maria, Gibson Jane, Walker Robert C, Rahman Saqib, Devonshire Ginny, Lloyd Megan A, Walters Zoë S, Fitzgerald Rebecca C, Rose-Zerilli Matthew J J, Underwood Tim J, On Behalf Of Occam |
| Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program. Translational oncology 2021 11 15 (1): 101266. Cassier Philippe A, Peyramaure Clémentine, Attignon Valery, Eberst Lauriane, Pacaud Camille, Boyault Sandrine, Desseigne Françoise, Sarabi Mathieu, Guibert Pierre, Rochefort Pauline, Marques Nathalie, Rivoire Michel, Dupré Aurélien, Peyrat Patrice, Terret Catherine, Ray-Coquard Isabelle, Coutzac Clélia, Pérol David, Blay Jean-Yves, Trédan Olivier, de la Fouchardière Christel |
| Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma. The oncologist 2021 1 26 (5): e756-e768. Yu Pengfei, Wang Yusheng, Yu Yanfei, Wang Aodi, Huang Ling, Zhang Yuan, Liu Wenjing, Wu Haiyan, Yao Ming, Du Yi-An, Cheng Xiangdo |
A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.
European journal of cancer (Oxford, England : 1990) 2021 5 151 94-105. Zhu Ying, Tian Jianbo, Peng Xiating, Wang Xiaoyang, Yang Nan, Ying Pingting, Wang Haoxue, Li Bin, Li Yue, Zhang Ming, Cai Yimin, Lu Zequn, Niu Siyuan, Li Yao, Zhong Rong, Chang Jiang, Miao Xiaopi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: